ID   KAD3_HUMAN              Reviewed;         227 AA.
AC   Q9UIJ7; B4DP58; D3DRI1; E7ET30; Q5VYW6; Q9H576; Q9HC01; Q9NPB4;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 163.
DE   RecName: Full=GTP:AMP phosphotransferase AK3, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03169};
DE            EC=2.7.4.10 {ECO:0000255|HAMAP-Rule:MF_03169};
DE   AltName: Full=Adenylate kinase 3 {ECO:0000255|HAMAP-Rule:MF_03169};
DE            Short=AK 3 {ECO:0000255|HAMAP-Rule:MF_03169};
DE   AltName: Full=Adenylate kinase 3 alpha-like 1 {ECO:0000255|HAMAP-Rule:MF_03169};
GN   Name=AK3 {ECO:0000255|HAMAP-Rule:MF_03169};
GN   Synonyms=AK3L1, AK6, AKL3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Liver;
RX   PubMed=11485571; DOI=10.1042/0264-6021:3580225;
RA   Noma T., Fujisawa K., Yamashiro Y., Shinohara M., Nakazawa A.,
RA   Gondo T., Ishihara T., Yoshinobu K.;
RT   "Structure and expression of human mitochondrial adenylate kinase
RT   targeted to the mitochondrial matrix.";
RL   Biochem. J. 358:225-232(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Pheochromocytoma;
RA   Li Y., Peng Y., Jiang Z., Gu W., Han Z., Chen Z.;
RT   "A novel gene expressed in human pheochromocytoma.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.48 ANGSTROMS).
RG   Structural genomics consortium (SGC);
RT   "Structure of human adenylate kinase 3-like 1.";
RL   Submitted (MAY-2005) to the PDB data bank.
CC   -!- FUNCTION: Involved in maintaining the homeostasis of cellular
CC       nucleotides by catalyzing the interconversion of nucleoside
CC       phosphates. Has GTP:AMP phosphotransferase and ITP:AMP
CC       phosphotransferase activities. {ECO:0000255|HAMAP-Rule:MF_03169,
CC       ECO:0000269|PubMed:11485571}.
CC   -!- CATALYTIC ACTIVITY: NTP + AMP = NDP + ADP. {ECO:0000255|HAMAP-
CC       Rule:MF_03169, ECO:0000269|PubMed:11485571}.
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03169}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=5; IntAct=EBI-3916527, EBI-743771;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000255|HAMAP-
CC       Rule:MF_03169, ECO:0000269|PubMed:11485571}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UIJ7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UIJ7-2; Sequence=VSP_043090;
CC       Name=3;
CC         IsoId=Q9UIJ7-3; Sequence=VSP_044876;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle and
CC       liver, moderately expressed in pancreas and kidney, and weakly
CC       expressed in placenta, brain and lung.
CC       {ECO:0000269|PubMed:11485571}.
CC   -!- DOMAIN: Consists of three domains, a large central CORE domain and
CC       two small peripheral domains, NMPbind and LID, which undergo
CC       movements during catalysis. The LID domain closes over the site of
CC       phosphoryl transfer upon GTP binding. Assembling and dissambling
CC       the active center during each catalytic cycle provides an
CC       effective means to prevent GTP hydrolysis. {ECO:0000255|HAMAP-
CC       Rule:MF_03169, ECO:0000305|Ref.10}.
CC   -!- SIMILARITY: Belongs to the adenylate kinase family. AK3 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03169}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB021870; BAA87913.1; -; mRNA.
DR   EMBL; AF183419; AAG09688.1; -; mRNA.
DR   EMBL; AK001553; BAA91753.1; -; mRNA.
DR   EMBL; AK001951; BAA91996.1; -; mRNA.
DR   EMBL; AK027534; BAB55183.1; -; mRNA.
DR   EMBL; AK098205; BAG53592.1; -; mRNA.
DR   EMBL; AK298200; BAG60470.1; -; mRNA.
DR   EMBL; AL136231; CAI41262.1; -; Genomic_DNA.
DR   EMBL; AL353151; CAI41262.1; JOINED; Genomic_DNA.
DR   EMBL; AL353151; CAH72282.1; -; Genomic_DNA.
DR   EMBL; AL136231; CAH72282.1; JOINED; Genomic_DNA.
DR   EMBL; AL136231; CAI41260.1; -; Genomic_DNA.
DR   EMBL; AL353151; CAI41260.1; JOINED; Genomic_DNA.
DR   EMBL; AL353151; CAH72283.1; -; Genomic_DNA.
DR   EMBL; AL136231; CAH72283.1; JOINED; Genomic_DNA.
DR   EMBL; CH471071; EAW58779.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58780.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58781.1; -; Genomic_DNA.
DR   EMBL; BC013771; AAH13771.1; -; mRNA.
DR   CCDS; CCDS56561.1; -. [Q9UIJ7-2]
DR   CCDS; CCDS56562.1; -. [Q9UIJ7-3]
DR   CCDS; CCDS6455.1; -. [Q9UIJ7-1]
DR   RefSeq; NP_001186781.1; NM_001199852.1. [Q9UIJ7-3]
DR   RefSeq; NP_001186782.1; NM_001199853.1. [Q9UIJ7-2]
DR   RefSeq; NP_001186784.1; NM_001199855.1. [Q9UIJ7-2]
DR   RefSeq; NP_001186785.1; NM_001199856.1. [Q9UIJ7-2]
DR   RefSeq; NP_057366.2; NM_016282.3. [Q9UIJ7-1]
DR   UniGene; Hs.732022; -.
DR   PDB; 1ZD8; X-ray; 1.48 A; A=1-227.
DR   PDBsum; 1ZD8; -.
DR   ProteinModelPortal; Q9UIJ7; -.
DR   SMR; Q9UIJ7; -.
DR   BioGrid; 119127; 8.
DR   IntAct; Q9UIJ7; 7.
DR   STRING; 9606.ENSP00000371230; -.
DR   iPTMnet; Q9UIJ7; -.
DR   PhosphoSitePlus; Q9UIJ7; -.
DR   BioMuta; AK3; -.
DR   DMDM; 23831297; -.
DR   OGP; Q9UIJ7; -.
DR   REPRODUCTION-2DPAGE; IPI00465256; -.
DR   UCD-2DPAGE; Q9UIJ7; -.
DR   EPD; Q9UIJ7; -.
DR   PaxDb; Q9UIJ7; -.
DR   PeptideAtlas; Q9UIJ7; -.
DR   PRIDE; Q9UIJ7; -.
DR   TopDownProteomics; Q9UIJ7-1; -. [Q9UIJ7-1]
DR   TopDownProteomics; Q9UIJ7-3; -. [Q9UIJ7-3]
DR   Ensembl; ENST00000359883; ENSP00000352948; ENSG00000147853. [Q9UIJ7-2]
DR   Ensembl; ENST00000381809; ENSP00000371230; ENSG00000147853. [Q9UIJ7-1]
DR   Ensembl; ENST00000447596; ENSP00000413933; ENSG00000147853. [Q9UIJ7-3]
DR   Ensembl; ENST00000611749; ENSP00000482308; ENSG00000147853. [Q9UIJ7-2]
DR   GeneID; 50808; -.
DR   KEGG; hsa:50808; -.
DR   UCSC; uc003ziq.4; human. [Q9UIJ7-1]
DR   CTD; 50808; -.
DR   DisGeNET; 50808; -.
DR   GeneCards; AK3; -.
DR   HGNC; HGNC:17376; AK3.
DR   HPA; HPA063324; -.
DR   MIM; 609290; gene.
DR   neXtProt; NX_Q9UIJ7; -.
DR   OpenTargets; ENSG00000147853; -.
DR   PharmGKB; PA164741184; -.
DR   eggNOG; KOG3078; Eukaryota.
DR   eggNOG; COG0563; LUCA.
DR   GeneTree; ENSGT00550000074679; -.
DR   HOGENOM; HOG000238772; -.
DR   HOVERGEN; HBG000458; -.
DR   InParanoid; Q9UIJ7; -.
DR   KO; K00944; -.
DR   OMA; NVPFQTI; -.
DR   OrthoDB; EOG091G06BH; -.
DR   PhylomeDB; Q9UIJ7; -.
DR   TreeFam; TF312916; -.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   ChiTaRS; AK3; human.
DR   EvolutionaryTrace; Q9UIJ7; -.
DR   GenomeRNAi; 50808; -.
DR   PRO; PR:Q9UIJ7; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147853; -.
DR   CleanEx; HS_AK3; -.
DR   CleanEx; HS_AK3L1; -.
DR   Genevisible; Q9UIJ7; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046899; F:nucleoside triphosphate adenylate kinase activity; IDA:BHF-UCL.
DR   GO; GO:0046033; P:AMP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0046039; P:GTP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0046041; P:ITP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0046051; P:UTP metabolic process; IDA:BHF-UCL.
DR   CDD; cd01428; ADK; 1.
DR   HAMAP; MF_00235; Adenylate_kinase_Adk; 1.
DR   HAMAP; MF_03169; Adenylate_kinase_AK3; 1.
DR   InterPro; IPR006259; Adenyl_kin_sub.
DR   InterPro; IPR000850; Adenylat/UMP-CMP_kin.
DR   InterPro; IPR033690; Adenylat_kinase_CS.
DR   InterPro; IPR007862; Adenylate_kinase_lid-dom.
DR   InterPro; IPR028586; AK3/Ak4_mitochondrial.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR23359; PTHR23359; 1.
DR   Pfam; PF05191; ADK_lid; 1.
DR   PRINTS; PR00094; ADENYLTKNASE.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF57774; SSF57774; 1.
DR   TIGRFAMs; TIGR01351; adk; 1.
DR   PROSITE; PS00113; ADENYLATE_KINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   GTP-binding; Kinase; Mitochondrion; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P08760}.
FT   CHAIN         2    227       GTP:AMP phosphotransferase AK3,
FT                                mitochondrial.
FT                                /FTId=PRO_0000158922.
FT   NP_BIND      17     22       GTP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   NP_BIND      64     66       AMP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   NP_BIND      91     94       AMP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   NP_BIND     137    138       GTP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   REGION       37     66       NMPbind. {ECO:0000255|HAMAP-
FT                                Rule:MF_03169, ECO:0000269|Ref.10}.
FT   REGION      127    164       LID. {ECO:0000255|HAMAP-Rule:MF_03169,
FT                                ECO:0000269|Ref.10}.
FT   BINDING      38     38       AMP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   BINDING      43     43       AMP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   BINDING      98     98       AMP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   BINDING     128    128       GTP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   BINDING     161    161       AMP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   BINDING     172    172       AMP. {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   BINDING     201    201       GTP; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03169}.
FT   MOD_RES      20     20       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES      34     34       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES      57     57       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES      64     64       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES      64     64       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES      80     80       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES      80     80       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES     174    174       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES     174    174       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES     189    189       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES     189    189       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   MOD_RES     203    203       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WTP7}.
FT   VAR_SEQ       1     70       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_043090.
FT   VAR_SEQ      51     90       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044876.
FT   CONFLICT      5      5       A -> G (in Ref. 1; BAA87913).
FT                                {ECO:0000305}.
FT   CONFLICT     38     38       S -> R (in Ref. 1; BAA87913).
FT                                {ECO:0000305}.
FT   CONFLICT     57     57       K -> Q (in Ref. 1; BAA87913).
FT                                {ECO:0000305}.
FT   CONFLICT     69     71       DVM -> YVT (in Ref. 1; BAA87913).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       K -> E (in Ref. 3; BAG60470).
FT                                {ECO:0000305}.
FT   STRAND        9     14       {ECO:0000244|PDB:1ZD8}.
FT   HELIX        20     30       {ECO:0000244|PDB:1ZD8}.
FT   STRAND       31     37       {ECO:0000244|PDB:1ZD8}.
FT   HELIX        38     48       {ECO:0000244|PDB:1ZD8}.
FT   HELIX        51     60       {ECO:0000244|PDB:1ZD8}.
FT   TURN         61     63       {ECO:0000244|PDB:1ZD8}.
FT   HELIX        68     80       {ECO:0000244|PDB:1ZD8}.
FT   STRAND       87     91       {ECO:0000244|PDB:1ZD8}.
FT   HELIX        96    103       {ECO:0000244|PDB:1ZD8}.
FT   STRAND      110    115       {ECO:0000244|PDB:1ZD8}.
FT   HELIX       118    125       {ECO:0000244|PDB:1ZD8}.
FT   STRAND      128    131       {ECO:0000244|PDB:1ZD8}.
FT   TURN        132    135       {ECO:0000244|PDB:1ZD8}.
FT   STRAND      136    139       {ECO:0000244|PDB:1ZD8}.
FT   TURN        140    142       {ECO:0000244|PDB:1ZD8}.
FT   TURN        152    154       {ECO:0000244|PDB:1ZD8}.
FT   HELIX       162    164       {ECO:0000244|PDB:1ZD8}.
FT   HELIX       166    189       {ECO:0000244|PDB:1ZD8}.
FT   STRAND      193    197       {ECO:0000244|PDB:1ZD8}.
FT   HELIX       201    212       {ECO:0000244|PDB:1ZD8}.
FT   TURN        213    215       {ECO:0000244|PDB:1ZD8}.
SQ   SEQUENCE   227 AA;  25565 MW;  98A0EDF4FD9C9CEF CRC64;
     MGASARLLRA VIMGAPGSGK GTVSSRITTH FELKHLSSGD LLRDNMLRGT EIGVLAKAFI
     DQGKLIPDDV MTRLALHELK NLTQYSWLLD GFPRTLPQAE ALDRAYQIDT VINLNVPFEV
     IKQRLTARWI HPASGRVYNI EFNPPKTVGI DDLTGEPLIQ REDDKPETVI KRLKAYEDQT
     KPVLEYYQKK GVLETFSGTE TNKIWPYVYA FLQTKVPQRS QKASVTP
//
